Home > Insider Trading > Vertex Pharmaceuticals Inc / Ma

Vertex Pharmaceuticals Inc / Ma (VRTX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
51 - 60
Next >>

Should You Invest in Vertex Pharmaceuticals Incorporated (VRTX)?

ClearBridge Investments, an investment management company, released its “ClearBridge Aggressive Growth Strategy” third quarter 2022 investor letter. A copy of the same can be downloaded here.

Keep Reading →

November 8th, 2022 - Hedge Fund Investor Letters News

Top 10 Gainers on Friday

All three key U.S. indices jumped this morning, thanks to better-than-expected earnings of giants like Apple Inc. (NASDAQ:AAPL), Intel Corporation (NASDAQ:INTC) and T-Mobile US, Inc. (NASDAQ:TMUS).

Keep Reading →

October 28th, 2022 - News

5 Best Pharma Stocks To Buy Now

Cardinal Health, Inc. (NYSE:CAH) offers investors a forward dividend yield of 2.91% as of October 21.

Keep Reading →

October 24th, 2022 - Hedge Funds News

5 Best Gene Editing Stocks To Buy

Graphite Bio, Inc. (NASDAQ:GRPH) is a clinical-stage gene editing company based in San Francisco, California. It develops therapies for life-threatening diseases in the United States.

Keep Reading →

October 14th, 2022 - Hedge Funds News

Is Vertex Pharmaceuticals Incorporated (VRTX) a Good Value Stock?

Carillon Tower Advisers, an investment management company, released its “Carillon Scout Mid Cap Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here.

Keep Reading →

October 7th, 2022 - Hedge Fund Investor Letters News